货号:GS40594
Reflocibart is a humanized IgG4 kappa monoclonal antibody targeting vascular endothelial growth factor B (VEGF-B). It binds to and neutralizes VEGF-B, thereby inhibiting VEGF-B-mediated signaling pathways involved in pathological angiogenesis, vascular leakage, and inflammatory responses. It is being investigated for the treatment of retinal vascular diseases such as diabetic macular edema and neovascular age-related macular degeneration (AMD).
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物